Has Kurt Meyer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,329 in general payments to Kurt Meyer, MD across 544 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kurt Meyer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kurt Meyer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kurt Meyer, MD

Radiation Oncology · Columbia, SCNPI 1962799452

Payments from drug & device makers

$12,329in general payments, 2019–2025

Across 544 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Novartis$944
Merck$703
Johnson & Johnson$664
Takeda Pharmaceuticals U.S.A., Inc.$620
Lilly USA, LLC$416
plus $8K from 54 others

What the payments were for

Food & beverage$12,329100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	60	$1,169
Novartis	41	$944
Merck	26	$703
Johnson & Johnson(2 entities)	21	$664
Takeda Pharmaceuticals U.S.A., Inc.	34	$620
Lilly USA, LLC	18	$416
Daiichi Sankyo Inc.	16	$392
Genentech USA, Inc.	19	$360
Bayer	15	$350
Pfizer	19	$326
Seagen Inc.	12	$296
Incyte Corporation	14	$290
Myovant Sciences Inc.	3	$264
Eisai Inc.	12	$250
GSK	10	$228
Astellas Pharma US Inc	12	$225
Bristol Myers Squibb	12	$224
EMD Serono, Inc.	9	$200
Puma Biotechnology, Inc.	10	$180
E.r. Squibb & Sons, L.L.C.	5	$176
Sobi, Inc	4	$174
Siemens Medical Solutions USA, Inc.	1	$171
Eagle Pharmaceuticals, Inc.	3	$168
Rigel Pharmaceuticals, Inc.	7	$157
Taiho Oncology, Inc.	8	$153
AVEO Pharmaceuticals, Inc.	7	$150
Sirtex Medical Inc	1	$149
Jazz Pharmaceuticals Inc.	9	$144
Amgen	7	$128
Karyopharm Therapeutics Inc.	7	$127
Ipsen Biopharmaceuticals, Inc	6	$125
ADC Therapeutics America, Inc.	6	$122
Regeneron Healthcare Solutions, Inc.	6	$122
Foundation Medicine, Inc.	1	$115
AbbVie	5	$112
Genmab U.S., Inc.	5	$112
Exelixis Inc.	7	$107
Spectrum Pharmaceuticals Inc.	5	$102
Progenics Pharmaceuticals, Inc.	1	$98
Boehringer Ingelheim	4	$95
Sanofi	4	$90
Servier Pharmaceuticals LLC	4	$90
Beigene USA, Inc.	5	$82
G1 Therapeutics, Inc.	3	$80
Sumitomo Pharma America, Inc.	4	$80
Kyowa Kirin, Inc.	5	$79
Immunocore Limited	3	$71
Array Biopharma Inc	5	$69
Stemline Therapeutics Inc.	3	$67
Mirati Therapeutics, Inc.	3	$56
Pharmaessentia USA Corporation	2	$53
Macrogenics, Inc.	2	$47
Morphosys, US Inc.	3	$46
CTI Biopharma Corp.	3	$41
Deciphera Pharmaceuticals Inc.	1	$41
Beone Medicines USA, Inc.	2	$38
Dova Pharmaceuticals	2	$35
Springworks Therapeutics, Inc.	2	$30
Gilead	1	$29
Helsinn Therapeutics (U.S.), Inc.	2	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,329 in reported general payments places this provider in the 90th percentile of 72 radiation oncology providers in South Carolina.

See all radiation oncology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$1,645,068

Medicare patients

434

Services billed

12,588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mometasone Furoate	48	$945
Tamsulosin Hcl	49	$748
Lidocaine Hcl ViscousLidocaine Hcl	16	$248

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Columbia

Kevin BlasColumbia$11K
Leonid ZamdborgColumbia$7K
Brandon StoneColumbia$3K
Edward DuffyColumbia$3K
Paul GoetowskiColumbia$847
James LittlesColumbia$789
Samuel CooperCharleston$540K
Daniel FriedSpartanburg$57K
Clinton MedberyCharleston$37K
Brian LallyCharleston$29K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →